SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting

N/ACompletedNCT04519372

University Hospital, Basel, Switzerland4,099 enrolled

Overview

The proportion of asymptomatic carriers of SARS-CoV-2 remains elusive, so the potential benefit of systematic screening during the SARS-CoV-2-pandemic is controversial. We investigate the proportion of asymptomatic inpatients who were identified by systematic screening for SARS-CoV-2 upon hospital admission. Adult patients admitted to the University Hospital Basel from 01.04.-14.06.2020 were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs. Each patient screened during the study period was retrospectively classified symptomatic or asymptomatic for COVID-19 based on medical chart review.

Study Type

OBSERVATIONAL

Enrollment

4,099

Conditions

Covid19 SARS-CoV-2

Interventions

Testing for SARS-CoV-2DIAGNOSTIC_TEST

All Patients admitted to the hospital were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs.

Medical Language ↔ Plain English

Inclusion Criteria: * The patient population is defined as all adult patients hospitalized in the University Hospital Basel from April 1st, 2020 to June 14th, 2020. Exclusion Criteria: * Outpatients * Patients with SARS-CoV-2 screening in the outpatient test center * Patients with a SARS-CoV-2 test more than 72 hours before hospital admission * Test not performed (for any reason)

Outcomes

Primary Outcomes

Proportion of SARS-CoV-2 -infected patients

We aim to determine the proportion of SARS-CoV-2-infected patients detected by systematic at-admission screening

Time frame: 01.04.2020-14.06.2020